Tatva Chintan Pharma Chem Reports Strong Q2 FY27 Results as Profit More Than Doubles
India, Oct. 19 -- The firm is a specialty chemical manufacturer from India, which manufactures products that can be utilized in various industrial applications. The firm is mainly into specialty chemicals and has one reportable business segment only.
The Nifty 50 traded at 22,848.05 down by 1.29%, while the Sensex fell 73,712.84, down by 1.36% on Monday. The shares of Tatva Chintan Pharma Chem are currently trading at Rs. 1,903.40, down by 2.09%. The company has a market capitalization of Rs. 4,452.44 crore. The stock' 52 week high is Rs. 2,008.70 and its 52 week high is Rs. 1,044.10. In the past 6 months the stock has delivered a return of 47.21%.
What's the News
Financial results of Tatva Chintan Pharma Chem Ltd for the quarter and h...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.